We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPEN:NASDAQOpendoor Technologies Inc Analysis

Data as of 2026-06-22 - not real-time

$4.47

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Opendoor is trading at $4.47, well below its 20‑day SMA of 4.69 and its 50‑day SMA of 4.86, indicating short‑term weakness, while the 200‑day SMA sits near 6.12 adding a longer‑term bearish backdrop. The RSI sits at 44.6, suggesting momentum is neutral but edging lower, and the MACD histogram is negative, confirming a bearish signal. Volatility is extreme at 67.6% over the past 30 days and beta exceeds 3.1, meaning the stock moves sharply with market swings. Despite a negative earnings profile (PE‑ratio below zero) the company generates solid operating cash flow of $1.08 B and free cash flow of $1.29 B, which cushions the balance sheet amid a debt‑to‑equity ratio above 140. The DCF‑derived fair value of $17.18 implies a substantial discount to market price, though the upside estimate is modest at under 8%. Recent material news of Russell 3000 inclusion provides a technical catalyst, yet retail hype and high borrowing costs continue to pressure the iBuyer model.
In the medium term the price must climb above the 20‑day SMA and sustain momentum to capture any upside, while the company’s ability to drive faster home resales toward adjusted EBITDA breakeven will be critical. The high volatility and sector stress suggest a cautious stance, but the deep discount to intrinsic value and positive cash generation offer a compelling value play for investors with a longer horizon. Institutional exposure from index inclusion could improve liquidity, yet the bearish technical picture and ongoing macro‑housing headwinds temper expectations. Overall, the stock presents a high‑risk, high‑reward profile that warrants disciplined position sizing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and neutral RSI
  • Extreme short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Russell 3000 inclusion boosting institutional demand
  • Significant discount to DCF fair value
  • Positive operating and free cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential to achieve adjusted EBITDA breakeven with faster resales
  • Long‑term undervaluation relative to intrinsic value
  • Resilient cash generation despite high debt

Key Metrics & Analysis

Financial Health

Revenue Growth-37.60%
Profit Margin-35.25%
P/E Ratio-377.5
ROE-173.61%
ROA-8.35%
Debt/Equity140.25
P/B Ratio4.5
Op. Cash Flow$1.1B
Free Cash Flow$1.3B
Industry P/E32.3

Technical Analysis

TrendBearish
RSI44.7
Support$4.08
Resistance$5.64
MA 20$4.69
MA 50$4.86
MA 200$6.12
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value$17.18
Target Price$4.82
Upside/Downside7.86%
GradeUndervalued
TypeBlend

Risk Assessment

Beta3.14
Volatility67.62%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.